Total Payments
$6,202
2024 Payments
$782.94
Companies
32
Transactions
461
Medicare Patients
22,614
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$5,971 (96.3%)
Education$231.22 (3.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,971 | 457 | 96.3% |
| Education | $231.22 | 4 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,542 | 227 | $0 (2024) |
| Amgen Inc. | $1,145 | 51 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $892.24 | 51 | $0 (2024) |
| PFIZER INC. | $441.96 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $270.49 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $245.52 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $224.97 | 3 | $0 (2018) |
| Boston Scientific Corporation | $193.45 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $173.98 | 10 | $0 (2023) |
| Merck Sharp & Dohme LLC | $167.81 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $782.94 | 60 | E.R. Squibb & Sons, L.L.C. ($358.78) |
| 2023 | $822.72 | 59 | E.R. Squibb & Sons, L.L.C. ($266.28) |
| 2022 | $1,104 | 76 | Amgen Inc. ($280.18) |
| 2021 | $546.81 | 31 | PFIZER INC. ($143.94) |
| 2020 | $576.69 | 37 | Amgen Inc. ($230.66) |
| 2019 | $636.78 | 69 | E.R. Squibb & Sons, L.L.C. ($201.66) |
| 2018 | $997.80 | 80 | Amgen Inc. ($343.04) |
| 2017 | $734.45 | 49 | E.R. Squibb & Sons, L.L.C. ($187.06) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.23 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.64 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.87 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.30 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.48 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.15 | General |
| Category: Cardiovascular | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.19 | General |
| Category: Cardiovascular | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.61 | General |
| Category: Cardiovascular | ||||||
| 08/06/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.28 | General |
| Category: Cardiovascular | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.19 | General |
| Category: Cardiovascular | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.33 | General |
| Category: Cardiovascular | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.23 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.40 | General |
| Category: Cardiovascular | ||||||
| 07/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $5.61 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 4,399 | 6,700 | $1.7M | $449,650 |
| 2022 | 27 | 6,309 | 9,535 | $2.0M | $497,599 |
| 2021 | 31 | 6,587 | 10,054 | $2.2M | $599,554 |
| 2020 | 31 | 5,319 | 8,395 | $2.2M | $585,734 |
Total Patients
22,614
Total Services
34,684
Medicare Billing
$2.1M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 584 | 1,281 | $320,650 | $110,778 | 34.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 245 | 245 | $330,750 | $84,546 | 25.6% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 244 | 483 | $96,015 | $43,602 | 45.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 193 | 769 | $115,350 | $32,901 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 286 | 473 | $141,900 | $29,123 | 20.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 216 | 217 | $181,195 | $28,643 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 276 | 347 | $69,400 | $21,453 | 30.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 140 | 140 | $66,500 | $18,829 | 28.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 243 | 243 | $92,340 | $11,863 | 12.8% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 15 | 15 | $13,500 | $10,123 | 75.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $26,650 | $9,249 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 170 | 171 | $76,095 | $9,102 | 12.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 39 | $41,820 | $7,928 | 19.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 544 | 709 | $42,540 | $7,185 | 16.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 739 | 1,061 | $40,858 | $6,560 | 16.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 56 | $21,000 | $5,195 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $7,390 | $3,195 | 43.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,950 | $1,863 | 37.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $8,170 | $1,496 | 18.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 24 | 27 | $9,450 | $1,342 | 14.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $9,240 | $1,266 | 13.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 19 | 19 | $4,275 | $1,130 | 26.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 49 | 50 | $5,000 | $491.12 | 9.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 20 | 20 | $3,000 | $328.90 | 11.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 21 | 34 | $1,020 | $311.78 | 30.6% |
About Dr. Jeevith Kanukunta, M.D
Dr. Jeevith Kanukunta, M.D is a Internal Medicine healthcare provider based in Mcdonough, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851338727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeevith Kanukunta, M.D has received a total of $6,202 in payments from pharmaceutical and medical device companies, with $782.94 received in 2024. These payments were reported across 461 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,971).
As a Medicare-enrolled provider, Kanukunta has provided services to 22,614 Medicare beneficiaries, totaling 34,684 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Mcdonough, GA
- Active Since 06/01/2006
- Last Updated 02/22/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1851338727
Products in Payments
- ELIQUIS (Drug) $1,607
- Repatha (Biological) $1,061
- ENTRESTO (Drug) $714.33
- CAMZYOS (Drug) $283.49
- XARELTO (Drug) $255.50
- LifeVest (Device) $245.52
- LEQVIO (Drug) $177.91
- VERQUVO (Drug) $167.81
- BRILINTA (Drug) $149.33
- AVVIGO Guidance System (Device) $147.50
- Corlanor (Drug) $83.69
- PRADAXA (Drug) $75.81
- Edarbi (Drug) $72.14
- Vascepa (Drug) $63.77
- VYNDAQEL (Drug) $61.55
- INJECTAFER (Drug) $58.65
- NEXLETOL (Drug) $55.15
- KENGREAL (Drug) $50.77
- MULTAQ (Drug) $50.21
- CHANTIX (Drug) $31.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mcdonough
Alicia Grady, M.d, M.D
Internal Medicine — Payments: $18,030
Internal Medicine $18,030
Dr. Andrew Doughan, Md, MD
Internal Medicine — Payments: $8,092
Internal Medicine $8,092
Muthusamy Sekar, M.d, M.D
Internal Medicine — Payments: $7,101
Internal Medicine $7,101
Meryl Braunstein, M.d, M.D
Internal Medicine — Payments: $4,155
Internal Medicine $4,155
Dr. Dandan Chen, M.d, M.D
Internal Medicine — Payments: $3,552
Internal Medicine $3,552
Dr. Pritam Polkampally, M.d, M.D
Internal Medicine — Payments: $3,483
Internal Medicine $3,483